Carepaths Revenue and Competitors

Vero Beach, FL USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Carepaths's estimated annual revenue is currently $652.5k per year.(i)
  • Carepaths's estimated revenue per employee is $72,500
  • Carepaths's pricing is $357 per year.

Employee Data

  • Carepaths has 9 Employees.(i)

Carepaths's People

NameTitleEmail/Phone
1
CEO / CTOReveal Email/Phone
2
Support ManagerReveal Email/Phone
3
Software EngineerReveal Email/Phone
4
PresidentReveal Email/Phone
5
Executive AssistantReveal Email/Phone
6
Software EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$76.6M25840%N/AN/A
#2
$84.1M4647%N/AN/A
#3
$1.3M15-6%N/AN/A
#4
$5.2M45N/AN/AN/A
#5
$5.6M48N/AN/AN/A
#6
$11.9M850%$26.3MN/A
#7
$72.5M414-2%N/AN/A
#8
$33.2M123N/AN/AN/A
#9
$1M12N/AN/AN/A
#10
$33.8M125N/AN/AN/A
#11
$1.5M17N/AN/AN/A
#12
$31.5M20912%$220.7MN/A
#13
$2.3M23N/AN/AN/A
#14
$3.7M32N/AN/AN/A
#15
$0.3M4N/AN/AN/A
#16
$14.4M998%N/AN/A
#17
$1.4M17N/AN/AN/A
#18
$8.4M39N/AN/AN/A
#19
$62.4M210N/AN/AN/A
#20
$6.5M30N/AN/AN/A
Add Company

What Is Carepaths?

keywords:saas

N/A

Total Funding

9

Number of Employees

$652.5k

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Carepaths News

2022-04-17 - How AI and Machine Learning Can Transform Utilization ...

By analyzing historical data and this real-world outcomes data, the vendor can create optimal, condition-specific care paths that are...

2022-03-22 - Fixing Prior Authorization: How to Improve Outcomes Using ...

If done correctly, recommended care paths can also take physician preferences, clinical workflow, and patient-specific data into account.

2022-03-22 - Cohere Health Advises Federal Government on the ...

By integrating these care paths into the prior authorization submission process, Cohere's digital UM platform reduces denial rates and medical...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.8M10-9%N/A
#2
$2.8M14-33%N/A
#3
$2.1M14-62%N/A
#4
$1.5M176%N/A
#5
$1.5M17N/AN/A